Prothena Corp (PRTA): Rentabilitas operasi

Logo korporat perusahaan Prothena Corporation PLC (PRTA)

The EBIT margin chart on GURU.Markets illustrates profitability trends, where the level of -73.00 represents the current value. Prothena Corporation (PRTA) maintains high authority in neurodegeneration therapy, which strengthens shareholder confidence. However, global conflicts and logistical complexities hinder international trials and raw material supplies. Innovation development relies on strategic alliances with pharmaceutical behemoths to combat Alzheimer's disease.

Prothena (PRTA): Margin bathi operasi saka 04.07.2022 nganti 19.11.2026

Prothena Biosciences - rincian analitis lan metrik utama (PRTA)

- rega lan prakiraan konsensus rega:
Analisis dhasar perusahaan:prothena.com
Barang utama Prothena Corp

Developing therapies for neurodegenerative pathologies involves colossal scientific risks and intense competitive pressure. Under such conditions, the operating margin model reflects the efficiency of R&D cost management relative to revenue. This metric determines the share of operating profit before taxes and interest, revealing the actual profitability of the core business. A decline in this ratio signals rising credit risks. Analyzing the historical operating margin allows for an assessment of the financial stability of Prothena Corporation (PRTA).

Pesaing langsung

Margin dodolan operasi BIIB|NBIX: Tingkat bathi operasi|Rentabilitas operasi Regencell Bioscience Ltd (RGC)|Margin operasi axsome.com (AXSM)|Margin operasi ACAD (acadia-pharm.com)|XENE - Margin dodolan operasi|vikingtherapeutics.com - Margin operasi|Supernus Pharma (SUPN) - Margin dodolan operasi|CPRX: Margin operasi|Denali Therapeutics Inc. (DNLI) - Margin operasi|Rentabilitas operasi Harmony Pharma|Rentabilitas operasi BHVN|Margin dodolan operasi AMLX (Amylyx Pharmaceuticals, Inc.)|Margin dodolan operasi Trevi Corp TRVI|Rentabilitas operasi praxismedicines.com PRAX|AVXL - Margin dodolan operasi|CeriBell EEG - Margin operasi|ALEC - Margin operasi|Annexon Inc. (ANNX) - Rentabilitas operasi|Margin dodolan operasi Omeros Corp|Margin dodolan operasi NGNE|ACIU: Tingkat bathi operasi|Margin dodolan operasi VYGR (Voyager Corp)|Margin dodolan operasi Neumora NMRA|Rentabilitas operasi Scilex Holding Company, Inc. SCLX|Tingkat bathi adhedhasar bathi operasi Tevogen Bio Inc.|ACOG - Rentabilitas operasi|Tingkat bathi adhedhasar bathi operasi Cognition Therapeutics (CGTX)|IKT (Inhibikase Therapeutics) - Margin dodolan operasi|Cassava Sciences Inc (SAVA) - Margin operasi|Margin dodolan operasi ASRT|Margin operasi coyatherapeutics.com|Margin operasi VTGN|Ovid Therapeutics - Rentabilitas dodolan miturut bathi operasi|Margin operasi ABOS (Acumen Pharmaceuticals, Inc)|CRVO - Margin dodolan operasi|ATHE - Rentabilitas operasi|Rentabilitas kegiatan operasi clene.com CLNN|PEPG: Margin operasi|Rentabilitas dodolan miturut bathi operasi JUNS|RLMD (Relmada Corp) - Margin operasi|Annovis Bio Inc (ANVS) - Rentabilitas kegiatan operasi|Rentabilitas operasi Grace Therapeutics, Inc. (GRCE)|AIFF (Firefly Neuro) - Tingkat bathi operasi|Rentabilitas operasi Klotho Neurosciences KLTO|NRSN: Rentabilitas dodolan miturut bathi operasi|RVPH: Margin dodolan operasi|MTVA: Rentabilitas operasi|NRXS (NeurAxis Inc) - Margin dodolan operasi|Margin dodolan operasi Helius Medical Technologies, Inc.|Rentabilitas operasi Passage Bio Inc.|Rentabilitas dodolan operasi bionomics.com.au NEUP|Margin operasi NERV|Margin operasi Athira Pharma Inc (ATHA)|Margin operasi ADXN (Addex Therapeutics Ltd.)|ALZN: Rentabilitas dodolan miturut bathi operasi|CYCN - Rentabilitas operasi|Rentabilitas dodolan operasi Protagenic Therapeutics, Inc.|KTTA (pasitheaclinics.com) - Margin dodolan operasi|Tingkat bathi adhedhasar bathi operasi Cortigent, Inc. CRGT|Rentabilitas operasi Avenue Therapeutics, Inc.|Margin dodolan operasi BrainStorm Cell Therapeutics Inc. (BCLI)|Rentabilitas operasi Cara Therapeutics, Inc (CARA)|Rentabilitas operasi CHRO (Chromocell Therapeutics Corp.)|Margin operasi ELYM (eliemtx.com)|intracellulartherapies.com - Rentabilitas operasi|LBPH: Margin dodolan operasi|Tingkat bathi operasi MRNS (Marinus Pharma)|NKGN (nkgenbiotech.com) - Margin dodolan operasi|Margin dodolan operasi NeuroBo Pharmaceuticals|SAGE (Sage Therapeutics Inc.) - Margin operasi|Neurotrope - Margin bathi operasi|Margin operasi TRVN|Rentabilitas kegiatan operasi Vigil Neuroscience, Inc.|Rentabilitas operasi Anew Medical, Inc. WENA|CERE - Margin dodolan operasi